Cargando…
A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin
[Image: see text] Proximity-based strategies to degrade proteins have enormous therapeutic potential in medicine, but the technologies are limited to proteins for which small molecule ligands exist. The identification of such ligands for therapeutically relevant but “undruggable” proteins remains ch...
Autores principales: | Shen, Fangfang, Zheng, Ge, Setegne, Mekedlawit, Tenglin, Karin, Izadi, Manizheh, Xie, Henry, Zhai, Liting, Orkin, Stuart H., Dassama, Laura M. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801508/ https://www.ncbi.nlm.nih.gov/pubmed/36589886 http://dx.doi.org/10.1021/acscentsci.2c00998 |
Ejemplares similares
-
Evolution of nanobodies specific for BCL11A
por: Yin, Maolu, et al.
Publicado: (2023) -
Opportunities and challenges of protein-based targeted protein degradation
por: Shen, Fangfang, et al.
Publicado: (2023) -
Modulation of CFTR gating by permeant ions
por: Yeh, Han-I, et al.
Publicado: (2015) -
Cell-Permeant and Photocleavable Chemical Inducer of Dimerization**
por: Zimmermann, Mirjam, et al.
Publicado: (2014) -
Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling
por: Schultz, Madeleine, et al.
Publicado: (2022)